Towards a comprehensive view of the herpes B virus
- PMID: 38035092
- PMCID: PMC10687423
- DOI: 10.3389/fimmu.2023.1281384
Towards a comprehensive view of the herpes B virus
Abstract
Herpes B virus is a biosafety level 4 pathogen and widespread in its natural host species, macaques. Although most infected monkeys show asymptomatic or mild symptoms, human infections with this virus can cause serious neurological symptoms or fatal encephalomyelitis with a high mortality rate. Herpes B virus can be latent in the sensory ganglia of monkeys and humans, often leading to missed diagnoses. Furthermore, the herpes B virus has extensive antigen crossover with HSV, SA8, and HVP-2, causing false-positive results frequently. Timely diagnosis, along with methods with sensitivity and specificity, are urgent for research on the herpes B virus. The lack of a clear understanding of the host invasion and life cycle of the herpes B virus has led to slow progress in the development of effective vaccines and drugs. This review discusses the research progress and problems of the epidemiology of herpes B virus, detection methods and therapy, hoping to inspire further investigation into important factors associated with transmission of herpes B virus in macaques and humans, and arouse the development of effective vaccines or drugs, to promote the establishment of specific pathogen-free (SPF) monkeys and protect humans to effectively avoid herpes B virus infection.
Keywords: diagnosis; herpes B virus; therapy; zoonotic pathogens; α-herpesvirus.
Copyright © 2023 Lu, Long, Sun and Gong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease.Emerg Infect Dis. 2003 Feb;9(2):246-50. doi: 10.3201/eid0902.020272. Emerg Infect Dis. 2003. PMID: 12603998 Free PMC article.
-
Discrimination of antibody to herpes B virus from antibody to herpes simplex virus types 1 and 2 in human and macaque sera.J Clin Microbiol. 2008 Jan;46(1):56-61. doi: 10.1128/JCM.00342-07. Epub 2007 Nov 7. J Clin Microbiol. 2008. PMID: 17989200 Free PMC article.
-
Multiple antibody targets on herpes B glycoproteins B and D identified by screening sera of infected rhesus macaques with peptide microarrays.PLoS One. 2014 Jan 31;9(1):e86857. doi: 10.1371/journal.pone.0086857. eCollection 2014. PLoS One. 2014. PMID: 24497986 Free PMC article.
-
Exposure to Macaque Monkey Bite.J Emerg Med. 2015 Nov;49(5):634-7. doi: 10.1016/j.jemermed.2015.06.012. Epub 2015 Aug 15. J Emerg Med. 2015. PMID: 26281802 Review.
-
[Human infection with simian herpes B virus in Africa].Sante. 2008 Jan-Mar;18(1):3-8. doi: 10.1684/san.2008.0101. Sante. 2008. PMID: 18684683 Review. French.
Cited by
-
Another potential zoonotic threat? Herpes B virus in the spotlight.New Microbes New Infect. 2024 May 7;60-61:101422. doi: 10.1016/j.nmni.2024.101422. eCollection 2024 Aug-Oct. New Microbes New Infect. 2024. PMID: 38765002 Free PMC article. No abstract available.
References
-
- Bolton ID. Chapter 5 - basic physiology of Macaca fascicularis. In: Bluemel J, Korte S, Schenck E, Weinbauer GF, editors. The Nonhuman Primate in Nonclinical Drug Development and Safety Assessment. San Diego: Academic Press; (2015). p. 67–86.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical